Scope Fluidics SA

As of March 31, 2026, Scope Fluidics SA carries a market capitalization of 449.89M, placing it among publicly traded companies globally. Its enterprise value stands at 313.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Scope Fluidics SA's next confirmed earnings release is scheduled for December 7, 2026.

As of March 31, 2026, Scope Fluidics SA has 3.17M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 4,022.93, and the price-to-book ratio stands at 3.02.

These figures are as of March 31, 2026. The EV/Sales ratio of 3,018.79 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 313.95M versus a market cap of 449.89M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Scope Fluidics SA maintains a current ratio of 11.81, meaning it holds 11.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.54, indicating elevated leverage, while an interest coverage ratio of -28.15 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Scope Fluidics SA posted a negative return on equity (ROE) of -34.36, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -28.28, reflecting losses generated across the asset base. Inventory turnover of 0.87 indicates how many times Scope Fluidics SA sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Scope Fluidics SA recorded 333,000.00 in income tax expense. The company reported a pretax loss of -48.50M and -48.84M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Scope Fluidics SA's stock has declined approximately 25.20% over the past 52 weeks. The 50-day moving average sits at 130.05, while the 200-day moving average is 132.27.

Over the twelve months ended March 31, 2026, Scope Fluidics SA generated 104,000.00 in revenue and converted that into -48.84M in net income, yielding earnings per share of -16.58. EBITDA reached -49.09M, while operating income came in at -51.38M.

As of March 31, 2026, Scope Fluidics SA holds 138.24M in cash and equivalents against 2.30M in total debt, resulting in a net debt position of -74.13M. Total book value stands at 148.96M, with working capital of 138.60M providing operational flexibility.

Scope Fluidics SA produced -51.42M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -6.08M in capital expenditures, free cash flow totaled -57.51M - equivalent to -19.52 per share.

Over the twelve months ended March 31, 2026, Scope Fluidics SA posted a gross margin of -3,873.08, reflecting its pricing power and cost economics. The operating margin of -49,403.85 and net profit margin of -46,959.62 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -13.75: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -13.51, meaning Scope Fluidics SA raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Scope Fluidics SA has an Altman Z-Score of 7.96, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.